Top Federal Drug Official Touts Therapeutic ‘Promise’ Of Psychedelics And Slams Schedule I Research Barriers

Marijuana Moment
By Kyle JaegerJan 26, 2026, 9:20 am79 pts
A top federal health official is again touting the therapeutic “promise” of psychedelics such as psilocybin and MDMA—though she says the drugs’ Schedule I status remains a research barrier to scientifically validating their efficacy. In a blog post this month, National Institution on Drug Abuse (NIDA) Director…

Read Article Share
Share Article
- email
- x.com
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Top Federal Drug Official Touts Therapeutic ‘Promise’ Of Psychedelics And Slams Schedule I Research Barriers 78

Missouri Cannabis Cultivators Fined for Using Out-of-State Seeds 63

Nexus Agriscience Acquires Biotech Institute Hemp IP to Expand Molecular Farming Platform 60

Chicago City Council Bans Intoxicating Hemp Products, Except Beverages 60

Federal Cannabis Law and Policy in 2026: Watch the Webinar Replay 55

Marijuana Use Isn’t A ‘Red Flag’ In The Dating Scene, Three In Four Americans Say In New Survey 54

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.